87341 Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative, multiple-step method; hepatitis B surface antigen

Name of the Procedure:

Infectious Agent Antigen Detection by Immunoassay Technique

• Common Names: Hepatitis B Surface Antigen Test, HBsAg Test
• Technical Terms: Enzyme Immunoassay (EIA), Enzyme-Linked Immunosorbent Assay (ELISA), Immunochemiluminometric Assay (IMCA)

Summary

This procedure involves testing a blood sample for the presence of the hepatitis B surface antigen (HBsAg), which is a protein on the surface of the hepatitis B virus. The test uses immunoassay techniques to qualitatively or semi-quantitatively detect this antigen, indicating a hepatitis B infection.

Purpose

The goal of this procedure is to determine if a person has an active hepatitis B infection. Detecting HBsAg can help diagnose hepatitis B, monitor the disease's progression, and guide treatment decisions.

Indications

• Symptoms such as jaundice, fatigue, abdominal pain, and dark urine
• Routine screening for high-risk individuals (e.g., healthcare workers, pregnant women, intravenous drug users)
• Follow-up in individuals with known exposure to hepatitis B
• Evaluation of patients with chronic liver disease

Preparation

• No specific preparation like fasting is usually required.
• Patients might be asked to provide a detailed medical history, especially concerning liver disease and potential exposure risks.
• A simple blood draw will be performed for the test.

Procedure Description

1. Sample Collection: A healthcare professional will draw a small amount of blood from the patient's vein.
2. Lab Analysis: The blood sample is processed using immunoassay techniques (EIA, ELISA, or IMCA).
   • The sample is mixed with reagents that bind to the HBsAg if present.
   • The reaction produces a detectable signal (e.g., a color change or light emission).
3. Result Interpretation: The signal is measured and compared against a control to determine the presence and possibly the amount of HBsAg.

Tools & Equipment:

• Blood collection kit (needle, tubes)
• Immunoassay equipment specific to the type of assay used (ELISA reader, chemiluminescence detector)

Duration

• Blood collection: about 5-10 minutes.
• Lab processing: typically several hours to a day, depending on the facility's workflow.

Setting

• Outpatient clinics, hospitals, or specialized diagnostic laboratories.

Personnel

• Phlebotomist or nurse for blood draw.
• Medical laboratory technologists for sample processing and analysis.

Risks and Complications

• Rare and generally minor: bruising at the needle site, slight dizziness or fainting.
• Extremely rare: infection at the site of blood draw.

Benefits

• A conclusive diagnosis of hepatitis B infection.
• Helps in monitoring disease progression and treatment effectiveness.
• Enables early intervention, potentially improving health outcomes.

Recovery

• Patients can resume normal activities immediately after the blood draw.
• There are no specific post-procedure care instructions.

Alternatives

• Hepatitis B Viral DNA testing for more detailed information on viral load.

• Liver function tests to assess liver health indirectly.

  Pros of Alternatives:

• Viral DNA testing provides more specific information on viral activity.

Cons of Alternatives:

• Might be more expensive and less accessible.
• Does not replace the need for antigen detection in routine screening situations.

Patient Experience

• Mild discomfort during blood draw.
• There might be minor soreness or bruising at the needle site for a short period.
• Overall, minimal discomfort and quick recovery with no prolonged pain or side effects.